Cargando…

Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer

Use of proteomic strategies to identify a risk classifier that estimates probability of distant recurrence in early-stage hormone receptor (HR)-positive breast cancer is relevant to physiological cellular function and therefore to intrinsic tumor biology. We used a 298-sample retrospective training...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramkumar, Charusheila, Buturovic, Ljubomir, Malpani, Sukriti, Kumar Attuluri, Arun, Basavaraj, Chetana, Prakash, Chandra, Madhav, Lekshmi, Doval, Dinesh Chandra, Mehta, Anurag, Bakre, Manjiri M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066801/ https://www.ncbi.nlm.nih.gov/pubmed/30083053 http://dx.doi.org/10.1177/1177271918789100

Ejemplares similares

Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients
por: Bakre, Manjiri M., et al.
Publicado: (2019)

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
por: Attuluri, Arun Kumar, et al.
Publicado: (2019)

Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
por: Sengupta, Aditya K., et al.
Publicado: (2020)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
por: Govindan, Sindhu, et al.
Publicado: (2020)

The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
por: Chandra Doval, Dinesh, et al.
Publicado: (2021)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma
por: Doval, Dinesh Chandra, et al.
Publicado: (2014)

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort
por: Gunda, Aparna, et al.
Publicado: (2022)

CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario
por: Sankaran, Satish, et al.
Publicado: (2019)

Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study
por: Doval, Dinesh Chandra, et al.
Publicado: (2013)

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer
por: Bajaj, Rajat, et al.
Publicado: (2020)

Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer
por: Dhaka, Sonia, et al.
Publicado: (2022)

A rare case of brain metastasis in a patient with osteosarcoma
por: Doval, Dinesh Chandra, et al.
Publicado: (2017)

Regulation of Senescence in Cancer and Aging
por: Kong, Yahui, et al.
Publicado: (2011)

Post-trial access to treatment for patients participating in clinical trials
por: Doval, Dinesh Chandra, et al.
Publicado: (2015)

Climate Change and Apple Farming in Indian Himalayas: A Study of Local Perceptions and Responses
por: Basannagari, Basavaraj, et al.
Publicado: (2013)

Cross-validation pitfalls when selecting and assessing regression and classification models
por: Krstajic, Damjan, et al.
Publicado: (2014)

Prospective validation of a transcriptomic severity classifier among patients with suspected acute infection and sepsis in the emergency department
por: Galtung, Noa, et al.
Publicado: (2022)

A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections
por: Mayhew, Michael B., et al.
Publicado: (2020)

Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2019)

Smurf2 regulates hematopoietic stem cell self-renewal and aging
por: Ramkumar, Charusheila, et al.
Publicado: (2014)

High Precision Prediction of Functional Sites in Protein Structures
por: Buturovic, Ljubomir, et al.
Publicado: (2014)

Breast Cancer Recurrence Presenting as Solitary Intraparotid Nodal Metastasis Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography: A Very Unusual Occurrence
por: Agrawal, Chaturbhuj Ramanand, et al.
Publicado: (2018)

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
por: Gunda, Aparna, et al.
Publicado: (2022)

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
por: Eshwaraiah, Mallikarjuna Siraganahalli, et al.
Publicado: (2023)

Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1
por: Ramkumar, Charusheila, et al.
Publicado: (2013)

The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2018)

Colonic polyp-rare site of metastasis from primary lung carcinoma: Clinical presentations and outcome
por: Agrawal, Chaturbhuj, et al.
Publicado: (2021)

The Optimization and Biological Significance of a 29-Host-Immune-mRNA Panel for the Diagnosis of Acute Infections and Sepsis
por: He, Yudong D., et al.
Publicado: (2021)

Eyelashes Trichomegaly: An Unusual Side Effect of Gefitinib Therapy
por: Agrawal, Chaturbhuj R, et al.
Publicado: (2018)

A rare case of lung adenocarcinoma: Unusual presentation with miliary mottling
por: Goyal, Pankaj, et al.
Publicado: (2020)

Non-familial cherubism
por: Singh, Anurag, et al.
Publicado: (2011)

ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017)

Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
por: Dakna, Mohammed, et al.
Publicado: (2010)

A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery
por: Doval, Dinesh Chandra, et al.
Publicado: (2020)

Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian population
por: Agrawal, Chaturbhuj, et al.
Publicado: (2021)

Laparoscopic appendicectomy in a child with multiple pituitary hormone deficiency
por: Bhaskar, S Bala, et al.
Publicado: (2013)

A Dirichlet process model for classifying and forecasting epidemic curves
por: Nsoesie, Elaine O, et al.
Publicado: (2014)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

The normal and fibrotic mouse lung classified by spatial proteomic analysis
por: Ciccimarra, Roberta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eg3rrjc9pqo6lnvqtpsguqp192